On July 2, 2019, the PMPRB Steering Committee on the Modernization of Price Review Process Guidelines released its final report summarizing its deliberations in providing stakeholder feedback on the PMPRB’s proposed new framework for regulation of the prices of patented medicines. PMPRB officials presented a draft of this report to the Steering Committee on May 13, 2019 (see our previous report here). The PMPRB will publish draft guidelines for public consultation once the Board has had an opportunity to review the Steering Committee’s final report and following final publication of the amended Patented Medicines Regulations.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
